MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with O

Oxybutynin

Oxybutynin 2.5mg tablets

Use with caution

Stability notes for Oxybutynin 2.5mg tablets

Light sensitive medicine. Store in light resistant container. Moisture sensitive medicine. Store in airtight (sealed) MCA. Stability study supports up to 4 weeks in a sealed MCA. Manufacturer recommends storing in original container.

Provenance

This recommendation is based on the products Ditropan 2.5mg tablets (Neon Healthcare Ltd) and Oxybutynin 5mg tablets (Tillomed Laboratories Ltd).

Suppliers (11) of Oxybutynin 2.5mg tablets
Oxybutynin 2.5mg tablets (A A H Pharmaceuticals Ltd)
Oxybutynin 2.5mg tablets (Accord-UK Ltd)
Oxybutynin 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Oxybutynin 2.5mg tablets (Almus Pharmaceuticals Ltd)
Oxybutynin 2.5mg tablets (Medihealth (Northern) Ltd)
Oxybutynin 2.5mg tablets (Morningside Healthcare Ltd)
Oxybutynin 2.5mg tablets (Niche Generics Ltd)
Oxybutynin 2.5mg tablets (Phoenix Healthcare Distribution Ltd)
Oxybutynin 2.5mg tablets (Sigma Pharmaceuticals Plc)
Oxybutynin 2.5mg tablets (Strides Pharma UK Ltd)
Oxybutynin 2.5mg tablets (Tillomed Laboratories Ltd)

Oxybutynin 3.9mg/24hours transdermal patches

No stability information

Stability notes for Oxybutynin 3.9mg/24hours transdermal patches

There are no stability notes for this medicine.

Supplier

Kentera 3.9mg/24hours patches (Accord-UK Ltd)

Oxybutynin 5mg/30ml bladder irrigation pre-filled syringes

No stability information

Stability notes for Oxybutynin 5mg/30ml bladder irrigation pre-filled syringes

There are no stability notes for this medicine.

Supplier

Oxybutynin 5mg/30ml bladder irrigation pre-filled syringes (Special Order)

Oxybutynin 5mg modified-release tablets

No stability information

Stability notes for Oxybutynin 5mg modified-release tablets

There are no stability notes for this medicine.

Suppliers

Oxybutynin 5mg modified-release tablets (Accord-UK Ltd)
Oxybutynin 5mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Oxybutynin 5mg modified-release tablets (Aspire Pharma Ltd)

Oxybutynin 5mg tablets

Use with caution

Stability notes for Oxybutynin 5mg tablets

Light sensitive medicine. Store in light resistant container. Moisture sensitive medicine. Store in airtight (sealed) MCA. Stability study supports up to 4 weeks in a sealed MCA. Manufacturer recommends storing in original container.

Provenance

This recommendation is based on the products Ditropan 5mg tablets (Neon Healthcare Ltd) and Oxybutynin 5mg tablets (Tillomed Laboratories Ltd).

Suppliers (11) of Oxybutynin 5mg tablets
Ditropan 5mg tablets (Sigma Pharmaceuticals Plc)
Oxybutynin 5mg tablets (A A H Pharmaceuticals Ltd)
Oxybutynin 5mg tablets (Accord-UK Ltd)
Oxybutynin 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Oxybutynin 5mg tablets (Almus Pharmaceuticals Ltd)
Oxybutynin 5mg tablets (Morningside Healthcare Ltd)
Oxybutynin 5mg tablets (Niche Generics Ltd)
Oxybutynin 5mg tablets (Phoenix Healthcare Distribution Ltd)
Oxybutynin 5mg tablets (Sigma Pharmaceuticals Plc)
Oxybutynin 5mg tablets (Strides Pharma UK Ltd)
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd)

Oxybutynin 10mg modified-release tablets

No stability information

Stability notes for Oxybutynin 10mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (5) of Oxybutynin 10mg modified-release tablets
Lyrinel XL 10mg tablets (Necessity Supplies Ltd)
Oxybutynin 10mg modified-release tablets (A A H Pharmaceuticals Ltd)
Oxybutynin 10mg modified-release tablets (Accord-UK Ltd)
Oxybutynin 10mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Oxybutynin 10mg modified-release tablets (Aspire Pharma Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.